In addition, we compared the therapeutic effects of paeoniflorin with escitalopram, which is commonly used in the clinic to treat patients with IFN-α-induced depression, and studied the anti-neuroinflammatory and antidepressant effects of both substances. This evidence concerns the gene IFNA1 and depressive disorder.